{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:05:04Z","timestamp":1766149504425,"version":"3.48.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","award":["RR2111"],"award-info":[{"award-number":["RR2111"]}],"id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","award":["RSD1429"],"award-info":[{"award-number":["RSD1429"]}],"id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01EB035545"],"award-info":[{"award-number":["1R01EB035545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["54CA210181, U54CA143837, U01CA200468, U01CA196403, U01CA214263, R01CA221971, R01CA248917, and R01CA218004"],"award-info":[{"award-number":["54CA210181, U54CA143837, U01CA200468, U01CA196403, U01CA214263, R01CA221971, R01CA248917, and R01CA218004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Andrew Sabin Family Fellowship"},{"DOI":"10.13039\/100020046","name":"Khalifa Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sheikh Ahmed Center for Pancreatic Cancer Research"},{"DOI":"10.13039\/100006775","name":"GE HealthCare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Phillips Healthcare"},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["14- 20-25-KOAY, 16-65-SING"],"award-info":[{"award-number":["14- 20-25-KOAY, 16-65-SING"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project Purple"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00616-9","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:06:32Z","timestamp":1765533992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response"],"prefix":"10.1038","volume":"11","author":[{"given":"Brian","family":"De","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Elganainy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoch","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunseon C.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno C.","family":"Odisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Wei D.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hop S.","family":"Tran Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun S.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicholas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyoung S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Kaseb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwal","family":"Raghav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Javle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal S.","family":"Noticewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma B.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Koong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Cristini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"616_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2007-1007302","volume":"14","author":"JN Vauthey","year":"1994","unstructured":"Vauthey, J. N. & Blumgart, L. H. Recent advances in the management of cholangiocarcinomas. Semin. liver Dis. 14, 109\u2013114 (1994).","journal-title":"Semin. liver Dis."},{"key":"616_CR2","doi-asserted-by":"publisher","first-page":"ii93","DOI":"10.1093\/annonc\/mdi712","volume":"16","author":"S Thongprasert","year":"2005","unstructured":"Thongprasert, S. The role of chemotherapy in cholangiocarcinoma. Ann. Oncol. 16, ii93\u2013ii96 (2005).","journal-title":"Ann. Oncol."},{"key":"616_CR3","doi-asserted-by":"publisher","unstructured":"Tao, R. et al. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J. Clin. Oncol. (2015). https:\/\/doi.org\/10.1200\/jco.2015.61.3778","DOI":"10.1200\/jco.2015.61.3778"},{"key":"616_CR4","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1245\/s10434-019-08142-9","volume":"27","author":"AC Smart","year":"2020","unstructured":"Smart, A. C. et al. Hypofractionated Radiation Therapy for Unresectable\/Locally Recurrent Intrahepatic Cholangiocarcinoma. Ann. Surg. Oncol. 27, 1122\u20131129 (2020).","journal-title":"Ann. Surg. Oncol."},{"key":"616_CR5","doi-asserted-by":"publisher","unstructured":"De, B. et al. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J. Pers. Med. 11 (2021). https:\/\/doi.org\/10.3390\/jpm11121270","DOI":"10.3390\/jpm11121270"},{"key":"616_CR6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/cncr.34223","volume":"128","author":"B De","year":"2022","unstructured":"De, B. et al. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128, 2529\u20132539 (2022).","journal-title":"Cancer"},{"key":"616_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/pme.10.5","volume":"7","author":"D Normolle","year":"2010","unstructured":"Normolle, D., Pan, C., Ben-Josef, E. & Lawrence, T. Adaptive trial of personalized radiotherapy for intrahepatic cancer. Per Med 7, 197\u2013204 (2010).","journal-title":"Per Med"},{"key":"616_CR8","doi-asserted-by":"crossref","unstructured":"Cristini, V. & Lowengrub, J. Multiscale modeling of cancer: an integrated experimental and mathematical modeling approach. (Cambridge University Press, 2010).","DOI":"10.1017\/CBO9780511781452"},{"key":"616_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100796","volume":"28","author":"RA Bekker","year":"2022","unstructured":"Bekker, R. A., Kim, S., Pilon-Thomas, S. & Enderling, H. Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system. Neoplasia 28, 100796 (2022).","journal-title":"Neoplasia"},{"key":"616_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1088\/0031-9155\/18\/1\/007","volume":"18","author":"KH Chadwick","year":"1973","unstructured":"Chadwick, K. H. & Leenhouts, H. P. A molecular theory of cell survival. Phys. Med Biol. 18, 78\u201387 (1973).","journal-title":"Phys. Med Biol."},{"key":"616_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2013.12.029","volume":"156","author":"K Leder","year":"2014","unstructured":"Leder, K. et al. Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell 156, 603\u2013616 (2014).","journal-title":"Cell"},{"key":"616_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0465-x","volume":"10","author":"S Prokopiou","year":"2015","unstructured":"Prokopiou, S. et al. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat. Oncol. 10, 159 (2015).","journal-title":"Radiat. Oncol."},{"key":"616_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ijrobp.2021.05.132","volume":"111","author":"MU Zahid","year":"2021","unstructured":"Zahid, M. U. et al. Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model. Int J. Radiat. Oncol. Biol. Phys. 111, 693\u2013704 (2021).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"616_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijrobp.2009.05.056","volume":"75","author":"S Eschrich","year":"2009","unstructured":"Eschrich, S. et al. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J. Radiat. Oncol. Biol. Phys. 75, 497\u2013505 (2009).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"616_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","volume":"18","author":"JG Scott","year":"2017","unstructured":"Scott, J. G. et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 18, 202\u2013211 (2017).","journal-title":"Lancet Oncol."},{"key":"616_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2022.04.044","volume":"114","author":"CX Wang","year":"2022","unstructured":"Wang, C. X. et al. Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer. Int J. Radiat. Oncol. Biol. Phys. 114, 163\u2013172 (2022).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"616_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller, A. B., Hoogstraten, B., Staquet, M. & Winkler, A. Reporting results of cancer treatment. Cancer 47, 207\u2013214 (1981).","journal-title":"Cancer"},{"key":"616_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 92, 205\u2013216 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"616_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"616_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-24","volume":"8","author":"H Jarraya","year":"2013","unstructured":"Jarraya, H. et al. Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat. Oncol. 8, 24 (2013).","journal-title":"Radiat. Oncol."},{"key":"616_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix, J. et al. Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J. Hepatol. 35, 421\u2013430 (2001).","journal-title":"J. Hepatol."},{"key":"616_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","volume":"55","author":"R Gillmore","year":"2011","unstructured":"Gillmore, R. et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J. Hepatol. 55, 1309\u20131316 (2011).","journal-title":"J. Hepatol."},{"key":"616_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ejca.2012.08.022","volume":"49","author":"BK Kim","year":"2013","unstructured":"Kim, B. K. et al. Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. Eur. J. Cancer 49, 826\u2013834 (2013).","journal-title":"Eur. J. Cancer"},{"key":"616_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1148\/radiol.2015142951","volume":"278","author":"V Tacher","year":"2016","unstructured":"Tacher, V. et al. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach. Radiology 278, 275\u2013284 (2016).","journal-title":"Radiology"},{"key":"616_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.diii.2020.09.004","volume":"102","author":"M Ghosn","year":"2021","unstructured":"Ghosn, M. et al. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Diagn. Inter. Imaging 102, 35\u201344 (2021).","journal-title":"Diagn. Inter. Imaging"},{"key":"616_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson, A. B. et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 19, 541\u2013565 (2021).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"616_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.trecan.2019.06.006","volume":"5","author":"H Enderling","year":"2019","unstructured":"Enderling, H., Alfonso, J. C. L., Moros, E., Caudell, J. J. & Harrison, L. B. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy. Trends Cancer 5, 467\u2013474 (2019).","journal-title":"Trends Cancer"},{"key":"616_CR28","doi-asserted-by":"publisher","first-page":"20190195","DOI":"10.1098\/rsif.2019.0195","volume":"16","author":"G Lorenzo","year":"2019","unstructured":"Lorenzo, G. et al. Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcome. J. R. Soc. Interface 16, 20190195 (2019).","journal-title":"J. R. Soc. Interface"},{"key":"616_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105430","volume":"25","author":"G Lorenzo","year":"2022","unstructured":"Lorenzo, G. et al. Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse. iScience 25, 105430 (2022).","journal-title":"iScience"},{"key":"616_CR30","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1158\/1078-0432.CCR-12-0084","volume":"18","author":"B Ribba","year":"2012","unstructured":"Ribba, B. et al. A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy. Clin. Cancer Res 18, 5071\u20135080 (2012).","journal-title":"Clin. Cancer Res"},{"key":"616_CR31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/math9070716","volume":"9","author":"O Leon-Triana","year":"2021","unstructured":"Leon-Triana, O. et al. Brain Metastasis response to stereotactic radio surgery: A mathematical approach. Mathematics 9, 716 (2021).","journal-title":"Mathematics"},{"key":"616_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.662840","volume":"11","author":"C Galeaz","year":"2021","unstructured":"Galeaz, C., Totis, C. & Bisio, A. Radiation Resistance: A Matter of Transcription Factors. Front Oncol. 11, 662840 (2021).","journal-title":"Front Oncol."},{"key":"616_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.621329","volume":"10","author":"LN He","year":"2020","unstructured":"He, L. N. et al. Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1\/PD-L1 Therapy. Front Oncol. 10, 621329 (2020).","journal-title":"Front Oncol."},{"key":"616_CR34","doi-asserted-by":"publisher","unstructured":"Ten Berge, D. et al. Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis. ERJ Open Res. 5 (2019). https:\/\/doi.org\/10.1183\/23120541.00179-2019","DOI":"10.1183\/23120541.00179-2019"},{"key":"616_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.21037\/atm.2019.02.14","volume":"7","author":"B Osorio","year":"2019","unstructured":"Osorio, B. et al. Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer. Ann. Transl. Med 7, 95 (2019).","journal-title":"Ann. Transl. Med"},{"key":"616_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5257-x","volume":"19","author":"C Dromain","year":"2019","unstructured":"Dromain, C. et al. Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors. BMC Cancer 19, 66 (2019).","journal-title":"BMC Cancer"},{"key":"616_CR37","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1634\/theoncologist.2018-0672","volume":"24","author":"A Lamarca","year":"2019","unstructured":"Lamarca, A. et al. Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients\u2019 Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study. Oncologist 24, e1082\u2013e1090 (2019).","journal-title":"Oncologist"},{"key":"616_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1148\/radiol.14140033","volume":"273","author":"J Chapiro","year":"2014","unstructured":"Chapiro, J. et al. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. Radiology 273, 746\u2013758 (2014).","journal-title":"Radiology"},{"key":"616_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.acra.2012.11.009","volume":"20","author":"V Tacher","year":"2013","unstructured":"Tacher, V. et al. Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad. Radio. 20, 446\u2013452 (2013).","journal-title":"Acad. Radio."},{"key":"616_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1200\/JCO.2018.36.4_suppl.228","volume":"36","author":"M Zaid","year":"2018","unstructured":"Zaid, M. et al. Discovery and validation of a quantitative, stromal-associated imaging biomarker of pancreatic ductal adenocarcinoma (PDAC). J. Clin. Oncol. 36, 228\u2013228 (2018).","journal-title":"J. Clin. Oncol."},{"key":"616_CR41","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00330-015-3595-5","volume":"25","author":"J Chapiro","year":"2015","unstructured":"Chapiro, J. et al. Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver. Eur. Radiol. 25, 1993\u20132003 (2015).","journal-title":"Eur. Radiol."},{"key":"616_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1586\/14737140.2015.978861","volume":"15","author":"J Chapiro","year":"2015","unstructured":"Chapiro, J., Lin, M., Duran, R., Schernthaner, R. E. & Geschwind, J. F. Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI. Expert Rev. anticancer Ther. 15, 199\u2013205 (2015).","journal-title":"Expert Rev. anticancer Ther."},{"key":"616_CR43","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10464","volume":"8","author":"A Namjan","year":"2020","unstructured":"Namjan, A., Techasen, A., Loilome, W., Sa-Ngaimwibool, P. & Jusakul, A. ARID1A alterations and their clinical significance in cholangiocarcinoma. PeerJ 8, e10464. https:\/\/doi.org\/10.7717\/peerj.10464 (2020).","journal-title":"PeerJ"},{"key":"616_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693295","volume":"11","author":"S Zhao","year":"2021","unstructured":"Zhao, S. et al. ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms. Front Oncol. 11, 693295 (2021).","journal-title":"Front Oncol."},{"key":"616_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1208\/s12248-015-9745-5","volume":"17","author":"S Desm\u00e9e","year":"2015","unstructured":"Desm\u00e9e, S., Mentr\u00e9, F., Veyrat-Follet, C. & Guedj, J. Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches. AAPS J. 17, 691\u2013699 (2015).","journal-title":"AAPS J."},{"key":"616_CR46","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/00949655.2013.878938","volume":"85","author":"C Mbogning","year":"2015","unstructured":"Mbogning, C., Kevin, B. & Lavielle, M. Joint modelling of longitudinal and repeated time-to-event data using nonlinear mixed-effects models and the stochastic approximation expectation\u2013maximization algorithm. J. Stat. Comput. Simul. 85, 1512\u20131528 (2015).","journal-title":"J. Stat. Comput. Simul."},{"key":"616_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mp.13769","volume":"47","author":"PC Park","year":"2020","unstructured":"Park, P. C. et al. Enhancement pattern mapping technique for improving contrast-to-noise ratios and detectability of hepatobiliary tumors on multiphase computed tomography. Med. Phys. 47, 64\u201374 (2020).","journal-title":"Med. Phys."},{"key":"616_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.adro.2019.10.002","volume":"5","author":"G Cazoulat","year":"2020","unstructured":"Cazoulat, G. et al. Vasculature-Driven Biomechanical Deformable Image Registration of Longitudinal Liver Cholangiocarcinoma Computed Tomographic Scans. Adv. Radiat. Oncol. 5, 269\u2013278 (2020).","journal-title":"Adv. Radiat. Oncol."},{"key":"616_CR49","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mp.14029","volume":"47","author":"A Sen","year":"2020","unstructured":"Sen, A. et al. Accuracy of deformable image registration techniques for alignment of longitudinal cholangiocarcinoma CT images. Med. Phys. 47, 1670\u20131679 (2020).","journal-title":"Med. Phys."},{"key":"616_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21037\/hbsn.2017.01.16","volume":"6","author":"EJ Koay","year":"2017","unstructured":"Koay, E. J., Odisio, B. C., Javle, M., Vauthey, J.-N. & Crane, C. H. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?. Hepatobiliary Surg. Nutr. 6, 105\u2013116 (2017).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"616_CR51","doi-asserted-by":"publisher","unstructured":"Dogra, P. et al. Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer. Pharmaceutical Res. (2022). https:\/\/doi.org\/10.1007\/s11095-022-03176-3","DOI":"10.1007\/s11095-022-03176-3"},{"key":"616_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv2930","volume":"11","author":"W Xia","year":"2025","unstructured":"Xia, W. et al. Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Sci. Adv. 11, eadv2930 (2025).","journal-title":"Sci. Adv."},{"key":"616_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02060-5","volume":"23","author":"P Dogra","year":"2024","unstructured":"Dogra, P. et al. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Mol. Cancer 23, 156 (2024).","journal-title":"Mol. Cancer"},{"key":"616_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60765-1","volume":"10","author":"K Schwarz","year":"2020","unstructured":"Schwarz, K., Dobiasch, S., Nguyen, L., Schilling, D. & Combs, S. E. Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines. Sci. Rep. 10, 3815 (2020).","journal-title":"Sci. Rep."},{"key":"616_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-485","volume":"12","author":"Q Li","year":"2012","unstructured":"Li, Q. et al. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner. BMC Cancer 12, 485 (2012).","journal-title":"BMC Cancer"},{"key":"616_CR56","doi-asserted-by":"publisher","unstructured":"Zaid, M. et al. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection. 10 (2020). https:\/\/doi.org\/10.3389\/fonc.2020.596931","DOI":"10.3389\/fonc.2020.596931"}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00616-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00616-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00616-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:01:47Z","timestamp":1766149307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00616-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00616-9","relation":{},"ISSN":["2056-7189"],"issn-type":[{"type":"electronic","value":"2056-7189"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D. reports honoraria from Sermo, Inc. and funding from the Radiological Society of North America. E.B.H. reports grants from Merck Serono. A.C.K. reports ownership of shares in Aravive, Inc. P.D. reports honoraria from ASTRO, ASCO, Imedex, and Bayer. E.J.K. reports grants from National Institutes of Health, Stand Up 2 Cancer, MD Anderson Cancer Center, Elekta, Varian, and GE Healthcare; personal fees from RenovoRx, Nanobiotix, AstraZeneca, and Taylor and Francis; and a consulting\/advisory role with Augmenix and Kallisio. All reported conflicts are outside the current work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}